Mosby's 2014 Nursing Drug Reference (171 page)

BOOK: Mosby's 2014 Nursing Drug Reference
10.58Mb size Format: txt, pdf, ePub

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

febuxostat (Rx)

(feb-ux′oh-stat)

Uloric

Func. class.:
Antigout drug, antihyperuricemic

Chem. class.:
Xanthene oxidase inhibitor

ACTION:

Inhibits the enzyme xanthine oxidase, thereby reducing uric acid synthesis; more selective for xanthine oxidase than allopurinol

USES:

Chronic gout, hyperuricemia

CONTRAINDICATIONS:

Hypersensitivity

Precautions:
Pregnancy (C), breast-feeding, children, renal/hepatic/cardiac/neoplastic disease, stroke, MI, organ transplant, Lesch-Nyhan syndrome

DOSAGE AND ROUTES
Calculator

• Adult:
PO
40 mg daily, may increase to 80 mg daily if uric acid levels are >6 mg/dl after 2 wk of therapy

Available forms:
Tabs 40, 80 mg

Administer:
PO route

• 
Without regard to meals or antacids; may crush and add to foods or fluids

• 
A few days before antineoplastic therapy

SIDE EFFECTS

CNS:
Weakness, flushing

CV:
MI, atrial fibrillation, atrial flutter, AV block,
bradycardia, hypo/hypertension, palpitations,
sinus tachycardia, stroke,
angina

EENT:
Retinopathy, cataracts, epistaxis

GI:
Nausea, vomiting, anorexia
, constipation, diarrhea, dyspepsia, hematemesis, hepatitis, hepatomegaly, weight gain/loss, cholecystitis, cholelithiasis, melena

GU:
Renal failure, urinary urgency/frequency/incontinence, nephrolithiasis, hematuria

HEMA:
Thrombocytopenia, anemia, pancytopenia, leukopenia, bone marrow suppression

INTEG:
Rash

MISC:
Arthralgia, gout flare

PHARMACOKINETICS

Peak 1-1.5 hr; excreted in feces, urine; half-life 5-8 hr; protein binding 99.2%

INTERACTIONS

Increase:
toxicity—azaTHIOprine

Increase:
xanthine nephropathy, calculi—rasburicase, antineoplastics

Increase:
myelosuppression—mercaptopurine, theophylline

NURSING CONSIDERATIONS
Assess:

• 
Hyperuricemia:
uric acid levels q2wk; uric acid levels should be ≤6 mg/dl, flares may occur during first 6 wk of treatment

• 
CBC, AST, BUN, creatinine before starting treatment, periodically

• 
Renal disease:
I&O ratio; increase fluids to 2 L/day to prevent stone formation and toxicity

• 
For rash, hypersensitivity reactions; discontinue

• 
Gout:
joint pain, swelling; may use with NSAIDs for acute gouty attacks and gout flare (first 6 wk)

Evaluate:

• 
Therapeutic response: decreased pain in joints, decreased stone formation in kidneys, decreased uric acid levels

Teach patient/family:

• 
That tabs may be crushed

• 
To take as prescribed; if dose is missed, to take as soon as remembered; not to double dose

• 
To increase fluid intake to 2 L/day unless contraindicated

• 
To avoid alcohol, caffeine because they will increase uric acid levels

• 
To report cardiovascular events to prescriber immediately

• 
Gout:
That flares may occur during first 6 wk of treatment

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

felodipine (Rx)

(fe-loe′-di-peen)

Plendil
, Renedil

Func. class.:
Antihypertensive, calcium channel blocker, antianginal

Chem. class.:
Dihydropyridine

Do not confuse:
Plendil
/pindolol/Pletal/PriLOSEC/Prinivil

ACTION:

Inhibits calcium ion influx across cell membrane, resulting in the inhibition of the excitation and contraction of vascular smooth muscle

USES:

Essential hypertension alone or with other antihypertensives

Unlabeled uses:
Hypertension in adolescents and children, angina pectoris; Prinzmetal’s angina (vasospastic)

CONTRAINDICATIONS:

Hypersensitivity to this product or dihydropyridines, sick sinus syndrome, 2nd- or 3rd-degree heart block, hypotension <90 mm Hg systolic

Precautions:
Pregnancy (C), breastfeeding, children, geriatric patients, CHF, hepatic injury, renal disease

DOSAGE AND ROUTES
Calculator

• Adult:
PO
5 mg/day initially; usual range 2.5-10 mg/day; max 10 mg/day; do not adjust dosage at intervals of <2 wk

• Geriatric:
PO
2.5 mg/day

Hepatic disease

• Adult:
PO
2.5-5 mg, max 10 mg/day

Hypertension in adolescent/child (unlabeled)

• Adolescent and child:
PO
2.5 mg initially, titrate upward, max 10 mg/day

Available forms:
Ext rel tabs 2.5, 5, 10 mg

Administer:
PO route

• 
Swallow whole; do not break, crush, or chew ext rel products

• 
Once daily with light meal; avoid grapefruit juice

SIDE EFFECTS

CNS:
Headache
, fatigue, drowsiness, dizziness, anxiety, depression, nervousness, insomnia, light-headedness, paresthesia, tinnitus, psychosis, somnolence, flushing

CV:
Dysrhythmia,
edema
,
CHF,
hypotension, palpitations,
MI, pulmonary edema,
tachycardia, syncope, AV block, angina

GI:
Nausea, vomiting, diarrhea, gastric upset, constipation, increased LFTs, dry mouth

GU:
Nocturia, polyuria

HEMA:
Anemia

INTEG:
Rash, pruritus

MISC:
Flushing, sexual difficulties, cough, nasal congestion, SOB, wheezing, epistaxis, respiratory infection, chest pain,
angioedema,
gingival hyperplasia

PHARMACOKINETICS

Peak plasma levels 2.5-5 hr, highly protein bound >99%, metabolized in liver, 0.5% excreted unchanged in urine, elimination half-life 11-16 hr

INTERACTIONS

Increase:
bradycardia, CHF—β-blockers, digoxin, phenytoin, disopyramide

Increase:
toxicity, hypotension—nitrates, alcohol, quiNIDine, zileuton, miconazole, diltiazem, delavirdine, quinupristin, dalfopristin, conivaptan, cycloSPORINE, cimetidine, clarithromycin, antiretroviral protease inhibitors, other antihypertensives, MAOIs, ketoconazole, erythromycin, itraconazole, propranolol

Decrease:
antihypertensive effects—NSAIDs, carBAMazepine, barbiturates, phenytoin

Drug/Herb

Increase:
antihypertensive effect—ginseng, ginkgo, hawthorn

Decrease:
antihypertensive effect—ephedra, St. John’s wort

Drug/Food

Increase:
felodipine level—grapefruit juice

NURSING CONSIDERATIONS
Assess:

• 
CHF:
I&O, weight daily; weight gain, crackles, dyspnea, edema, jugular venous distention

• 
Cardiac status: B/P, pulse, respiration; ECG periodically

• 
Angina pain:
location, duration, intensity; ameliorating, aggravating factors

Evaluate:

• 
Therapeutic response: decreased B/P, decreased anginal attacks, increased activity tolerance

Teach patient/family:

• 
To avoid hazardous activities until stabilized on product, dizziness no longer a problem

• 
To avoid OTC products, alcohol unless directed by prescriber; to limit caffeine consumption

• 
About the importance of complying with all areas of medical regimen: diet, exercise, stress reduction, product therapy

• 
That tablets may appear in stools but are insignificant

• 
To report dyspnea, palpitations, irregular heart beat, swelling of extremities, nausea, vomiting, severe dizziness, severe headache

• 
To change positions slowly to prevent orthostatic hypotension

• 
To obtain correct pulse; to contact prescriber if pulse <50 bpm

TREATMENT OF OVERDOSE:

Atropine for AV block, vasopressor for hypotension

Other books

The Gift by Vladimir Nabokov
Oblivion by Adrianne Lemke
The Black Feather by Olivia Claire High
Private Sorrow, A by Reynolds, Maureen
Her Keepers by Hazel Gower
Dark Moon by Elizabeth Kelly
One Dead Seagull by Scot Gardner
Child Wonder by Roy Jacobsen